ライフサイエンスコーパス: bacteremic

1 lpha, despite the fact that the animals were bacteremic.

2 tently Bartonella koehlerae seroreactive and bacteremic.

3 r, 4/12 (33%) of the diabetic rabbits became bacteremic.

4 All animals were bacteremic 1 hr after challenge (mean 3.6 x 10(5) colony

5 None of the cats became bacteremic after secondary challenge, and all had higher

6 s were hospitalization for pneumococcal CAP (bacteremic and nonbacteremic cases) and all-cause CAP.

7 Both bacteremic and nonbacteremic pneumonia seasonality peake

8 pecimens, 31 (93.9%) were judged to be truly bacteremic and/or candidemic based on a medical chart re

9 R-ESI-MS were judged to be truly or possibly bacteremic and/or candidemic, respectively.

10 ive in preventing vaccine-type pneumococcal, bacteremic, and nonbacteremic community-acquired pneumon

11 necrosis at the site of inoculation, became bacteremic, and subsequently died.

12 began receiving ciprofloxacin after becoming bacteremic, and treatment was continued for 10 days.

13 ted blood following acquisition feeding on a bacteremic animal host.

14 Meningitis was detected in 20 to 50% of bacteremic animals, and mortality invariably followed ba

15 Patients with infection from bacteremic Bartonella spp., tested using Bartonella Alph

16 All septic mice were bacteremic, but no differences in bacterial load were id

17 remic by day 7, and all nine cats had become bacteremic by 14 days postinfection.

18 All B. henselae-inoculated cats were bacteremic by 2 weeks after infection.

19 Seven of nine cats were bacteremic by day 7, and all nine cats had become bacter

20 monly used vasopressor, norepinephrine, in a bacteremic canine model of Pseudomonas aeruginosa sepsis

21 on, 36.4% catheter-related infections, 57.1% bacteremic catheter-related infections).

22 s (1.5%, 2.09/1,000 catheter-days) presented bacteremic catheter-related infections.

23 ts, no conclusion could be reached regarding bacteremic catheter-related infections.

24 Cat fleas removed from bacteremic cattery cats transmitted B. henselae to five

25 ins could not be explained by differences in bacteremic clearance or initial adherence to sterile veg

26 Six (19%) of 31 Bartonella bacteremic coyotes exhibited the strain profile that was

27 By PFGE analysis, three Bartonella bacteremic coyotes were infected by a strain identical t

28 The other 25 bacteremic coyotes were infected with a strain that was

29 s penetrate the epithelial barrier and cause bacteremic disease or spread within the respiratory trac

30 therapy and duration of therapy in selected bacteremic disease, such as dental bacteremias and bacte

31 score at admission and among persons who had bacteremic disease.

32 Survival, predictors of bacteremic disseminated tuberculosis, and predictors of

33 total lymphocyte count were associated with bacteremic disseminated tuberculosis.

34 mprovement in bacterial clearance, decreased bacteremic dissemination, and attenuated lung damage.

35 ia in lungs, which correlated with increased bacteremic dissemination.

36 NALT) plus cervical lymphadenopathy prior to bacteremic dissemination.

37 Organs transplanted from bacteremic donors do not transmit bacterial infection or

38 There were 95 (5.1%) bacteremic donors from a total of 1775, from whom 212 re

39 Forty-six (48%) of the bacteremic donors had pathogens in their blood.

40 tient survival for recipients of organs from bacteremic donors was not significantly different from r

41 with those for recipients of organs from non-bacteremic donors.

42 -associated pneumonia were more likely to be bacteremic during their ICU stay (36 [28%] vs. 22 [3%];

43 subclone (ST131-H30) responsible for 28% of bacteremic E. coli infections over a 3-yr period.

44 isolates, all belonging to uropathogenic and bacteremic E. coli strains previously defined as clonal

45 nts were seen with the use of MAB-T88 in the bacteremic enterobacterial common antigen group (p <.05)

46 A bacteremic episode was defined as two positive blood cul

47 Bacteremic episodes in patients at St Jude Children's Re

48 xperience with this procedure, we noted that bacteremic episodes tended to occur simultaneously with

49 Positive BC results from 292 bacteremic episodes were reviewed.

50 Significantly fewer bacteremic episodes with Gram-negative organisms occurre

51 b cell expansion, diminished the severity of bacteremic episodes, and led to the eventual resolution

52 tibody responses are required to resolve the bacteremic episodes.

53 witch recombination efficiently resolved all bacteremic episodes.

54 aluated by removing fleas from the naturally bacteremic, flea-infested cattery cats and transferring

55 In patients with bacteremic HAP, telavancin resulted in clearance of bloo

56 Of 2,139 bacteremic hospitalized patients, 592 (28%) received sta

57 io, 7.1; P<0.05), a type often implicated in bacteremic human cases.

58 idal Salmonella (iNTS) disease causes severe bacteremic illness among adults with human immunodeficie

59 ogy, diagnosis, prevention, and treatment of bacteremic illness in children.

60 Most pathogens in febrile, bacteremic infants 90 days of age or younger hospitalize

61 Out of 1928 cases of GAS bacteremic infection, 278 were caused by emm89 GAS.

62 heters, which are the most frequent foci for bacteremic infection.

63 COSA bacteremic infections are as common as those due to pneu

64 ion were used to compare differences between bacteremic infections due to emm89 GAS belonging to diff

65 tro susceptibility and a propensity to cause bacteremic infections in patients with CF.

66 utcome were polymicrobial, inflammatory, and bacteremic infections requiring more than 1 debridement,

67 edical condition." Overall, 48% of S. aureus bacteremic infections were COSA (incidence, 17 cases/100

68 by which B. henselae establishes persistent bacteremic infections within cats.

69 Two patients had bacteremic infections, 4 had abdominal infections withou

70 primarily blood borne (86%), made up 21% of bacteremic infections, and had a recurrent incidence of

71 epidemiological characteristics of emm89 GAS bacteremic infections, including 7-day and 30-day case-f

72 ransplantation of organs from donors who are bacteremic is controversial.

73 sion of type 3 secretion system exotoxins in bacteremic isolates of P. aeruginosa confers poor clinic

74 Of the bacteremic isolates, all but one isolate, drawn from a p

75 susceptibility testing were performed on 499 bacteremic isolates.

76 ever, control SPF kittens housed with highly bacteremic kittens in the absence of fleas did not becom

77 nal PCV13 serotypes are more likely to cause bacteremic LRTI and empyema in healthy vaccinated childr

78 Thus, gram-negative bacteremic lung infection and secondary alveolar H/R upr

79 ipheral blood leukocytes (PBL) circulated in bacteremic mice and could establish organ infection in v

80 The rescue of bacteremic mice could be effected only by phage strains

81 w lin(-)c-kit(+)Sca-1(+) cells isolated from bacteremic mice showed an increase in CFU-granulocyte/ma

82 The ability of this phage to rescue bacteremic mice was demonstrated to be due to the functi

83 sed AM apoptosis and increased the number of bacteremic mice, indicating a novel role for caspase act

84 In our studies involving bacteremic mice, the problem of the narrow host range of

85 ar type 3 strain in diluted whole blood from bacteremic mice.

86 to monitor the blood-borne stage in a murine bacteremic model of P. aeruginosa infection.

87 pared with that of the wild-type strain in a bacteremic mouse model.

88 entional antibiotics typically used to treat bacteremic newborns (ampicillin and gentamicin).

89 Although most animals became bacteremic, only those with a severe systemic inflammati

90 We calculated rates of transmission from bacteremic or fungemic donors to their recipients and co

91 carefully inspect the PVC insertion site in bacteremic or fungemic patients, and remove PVCs associa

92 ted on the basis of the patients having been bacteremic or having received vancomycin as the definiti

93 ted from hospital-based patients with either bacteremic or nonbacteremic infections.

94 he multicenter cohort) and (2) isolates from bacteremic or nonbacteremic patients with pneumonia (PP)

95 Between 1986 and 1995, two thirds of all bacteremic organisms were cultured from intravascular ca

96 sion tree to determine the likelihood that a bacteremic patient was infected with an ESBL producer.

97 phylococcus aureus isolates recovered from a bacteremic patient were shown to acquire gradually incre

98 ical decision tree can be used to estimate a bacteremic patient's likelihood of infection with ESBL-p

99 greater for CP-CRE compared with non-CP-CRE bacteremic patients (adjusted odds ratio, 4.92; 95% conf

100 as the exposure variable, in the subgroup of bacteremic patients (n = 207) and in the propensity-matc

101 itional methods for identifying pathogens in bacteremic patients are slow (24-48+ h).

102 Five (32%) of 16 bacteremic patients died vs. none of the 95 control pati

103 isolates and the clinical characteristics of bacteremic patients enrolled in a phase III trial of S.

104 occal and enterococcal strains isolated from bacteremic patients expressed proteins that comigrated w

105 rty-seven unique MRSA isolates obtained from bacteremic patients in multicenter prospective clinical

106 ck were compared with a cohort of 376 purely bacteremic patients in septic shock.

107 sent a viable adjuvant therapy for septic or bacteremic patients in the intensive care unit.

108 Among isolates from PP, those from bacteremic patients overexpressed nonsignificantly more

109 mmonly used antibiotics for the treatment of bacteremic patients throughout the 1970s were amoxicilli

110 Bacteremic patients were more likely to have benign pros

111 Among MSSA-bacteremic patients who did not die or get hospitalized

112 Septic shock was identified in 43% of bacteremic patients with type 3 secretion system+ isolat

113 Of 25 bacteremic patients, 14 (10 with gram-positive bacteremi

114 was significantly increased in the serum of bacteremic patients.

115 re more frequent in the urinary strains from bacteremic patients.

116 illing of S. aureus were detected in 9 of 15 bacteremic patients.

117 or agr are associated with worse outcomes in bacteremic patients.

118 rates (per 1000 person-years) were 0.21 for bacteremic pneumococcal CAP (0.14 vs 0.26 among vaccinat

119 rs ago) was associated with reduced risks of bacteremic pneumococcal CAP (hazard ratio [HR], 0.38; 95

120 urine antigen test was positive in 51 of 58 bacteremic pneumococcal cases (sensitivity, 88%; 95% con

121 alveoli, thereby protecting the host against bacteremic pneumococcal disease.

122 survival among critically ill patients with bacteremic pneumococcal illness.

123 e, and rapid test for the early diagnosis of bacteremic pneumococcal infections in adult patients, ev

124 ochromatographic assay, for the diagnosis of bacteremic pneumococcal infections in hospitalized adult

125 eumoniae urine antigen test in patients with bacteremic pneumococcal infections.

126 admission from 14 (27%) of 51 patients with bacteremic pneumococcal pneumonia and 11 (37%) of 30 wit

127 ried significantly by clinical presentation: bacteremic pneumococcal pneumonia incidence peaked in la

128 at combination antibiotic therapy for severe bacteremic pneumococcal pneumonia may reduce mortality.

129 anti-pneumolysin IgG than did patients with bacteremic pneumococcal pneumonia or uninfected control

130 was associated with significant increases in bacteremic pneumonia cases (attributable percentage, 15.

131 Using our bacteremic pneumonia model we further investigated the e

132 In a bacteremic pneumonia model, we observed a PcpA-dependent

133 lower respiratory tract infections (V-LRI), bacteremic pneumonia, nonbacteremic pneumonia and nonpne

134 cantly during convalescence in patients with bacteremic pneumonia, reaching levels observed in nonbac

135 e cell recruitment to the lung tissue during bacteremic pneumonia.

136 ons (31.4%; 95% CI, 8.8%-51.4%) but not with bacteremic pneumonia.

137 solated from the blood and nasal passages of bacteremic rats to colonize the nasopharynx and invade t

138 Bacteremic relapse was similar between the two groups (1

139 mbination therapy on duration of bacteremia, bacteremic relapse, and acute kidney injury (AKI).

140 We established a mouse model of bacteremic S. aureus infection to correlate bacteriologi

141 cquired pneumonia, cure rates for those with bacteremic S. aureus pneumonia were 41% (9/22, telavanci

142 the liver during normotensive gram-negative bacteremic sepsis alters the kinetics of circulating end

143 mg/kg) markedly improved survival in lethal bacteremic sepsis and aspiration pneumonia models of XDR

144 .5, or 25 microg x kg-1 x hr-1 ) 3 hrs after bacteremic sepsis maintained a normal mean arterial pres

145 led Escherichia coli (1 x 10(9) CFU/kg), and bacteremic sepsis was induced 12 h later by infusion of

146 nflammation early after normotensive E. coli bacteremic sepsis.

147 as 60% in candidemic septic shock and 46% in bacteremic septic shock (p =.38).

148 tion II: candidemic septic shock, 32 +/- 10; bacteremic septic shock, 30 +/- 8; p =.44).

149 le organ failure compared with patients with bacteremic septic shock.

150 standardized order set for the management of bacteremic severe sepsis was associated with greater flu

151 standardized order set for the management of bacteremic severe sepsis.

152 cid metabolite release in a porcine model of bacteremic shock and b) selectively block PAF, thromboxa

153 lar O2 tension commonly follow gram-negative bacteremic shock that progresses to the acute respirator

154 come, primarily in models of endotoxemic and bacteremic shock.

155 ations to cause the pulmonary derangement of bacteremic shock.

156 d cardiopulmonary dysfunction, as well as of bacteremic shock.

157 htly improved bacterial clearance during the bacteremic stage compared with controls.

158 de that inhibition of C5 cleavage during the bacteremic stage of sepsis could be an important therape

159 fferent bacterial species recovered from 151 bacteremic subjects.

160 me, adolescents and young adults who develop bacteremic symptoms should be aggressively treated with

161 ths old were significantly less likely to be bacteremic than cats <or=6 months old (odds ratio = 0.18

162 strains were isolated were more likely to be bacteremic than were patients with other A. baumannii is

163 Bacteremic trauma victims have a higher risk of death th

164 All cats remained persistently bacteremic until they were treated 4 to 7 weeks after pr

165 P surgery, only 25% of C10-treated mice were bacteremic versus 85% of the control group that exhibite

166 At 24 h, 21 of 27 Mac-1(-/-) mice were bacteremic, vs 15 of 25 WT (p = 0.05); no difference was

167 One kitten that remained bacteremic was treated unsuccessfully with enrofloxacin,

168 No cats bacteremic with B. clarridgeiae were found.

169 Cats bacteremic with B. henselae constitute a large reservoir

170 alifornia, 31 animals (28%) were found to be bacteremic with B. vinsonii subsp. berkhoffii and 83 ani

171 in women than in men; it was also found that bacteremic women were more likely to be infected with HI